Oncimmune Holdings Earnings Estimate

ONC Stock   15.35  0.20  1.32%   
By analyzing Oncimmune Holdings' earnings estimates, investors can diagnose different trends across Oncimmune Holdings' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Oncimmune Holdings plc is based on EPS before non-recurring items and includes expenses related to employee stock options. Oncimmune Holdings is projected to generate -2.6975 in earnings per share on the 31st of May 2018. Oncimmune Holdings earnings estimates module stress-tests analyst consensus about projected Oncimmune Holdings plc EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Oncimmune Holdings, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Oncimmune Holdings' earnings estimates, investors can diagnose different trends across Oncimmune Holdings' analyst sentiment over time as well as compare current estimates against different timeframes. As of November 27, 2024, Gross Profit is expected to decline to about 716.4 K
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncimmune Holdings plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Oncimmune Holdings Earnings per Share Projection vs Actual

About Oncimmune Holdings Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Oncimmune Holdings earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Oncimmune Holdings estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Oncimmune Holdings fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-38.3 M-40.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Oncimmune Stock

Oncimmune Holdings financial ratios help investors to determine whether Oncimmune Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncimmune with respect to the benefits of owning Oncimmune Holdings security.